Nevertheless, these findings were contradicted by recent studies showing that MS patients with MEFV mutations had similar disease course, clinical features, severity, response to therapy, and progression to patients with no MEFV mutations (95, 96, 99). Here, MEFV is linked to myeloid sarcoma.